This paper shows 21 patients with @entity1701 , that were diagnosed after @entity715 , recurrent fetal loss or @entity882 . @entity4555 was detected in 18, anticardiolipin antibodies in 15 and VDRL test was positive in 6 @entity1 . Nine @entity1 had recurrent @entity49 , 6 @entity358 , 9 recurrent fetal loss and 15 were with low platelet count. Secondary prevention with oral anticoagulants was applied according to the level of INR 2.5-3.5. Only one @entity1 relapsed due to deficient anticoagulation. Three pregnant @entity1 were treated with @entity117 , and low molecular weight heparin, alone or in combination with @entity229 . All of them had recurrent spontaneous abortions between 20 and 28 weeks of gestation. In conclusion, early diagnosis of @entity1701 is very important. Secondary prevention of @entity1031 complications is recommended according to the level of INR > or = 3. For the prevention of fetal loss we have not agreed upon treatment of all @entity1 . Further studies are needed to define more precisely the optimal type, intensity, and the duration of therapy.

The management of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity882 :: ('MESH:D013921', 'Disease') :: ['thrombocytopenia'] @entity229 :: ('MESH:D011241', 'Chemical') :: ['prednisone'] @entity117 :: ('MESH:D001241', 'Chemical') :: ['aspirin'] @entity49 :: ('MESH:D019851', 'Disease') :: ['venous thrombosis'] @entity1701 :: ('MESH:D016736', 'Disease') :: ['antiphospholipid syndrome'] @entity4555 :: ('MESH:C531622', 'Disease') :: ['Lupus anticoagulant'] @entity358 :: ('MESH:D008171', 'Disease') :: ['pulmonary embolus'] @entity1031 :: ('MESH:D013923', 'Disease') :: ['thromboembolic'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombosis']
@entity1701 :: (MESH:D016736,Disease) :: ['antiphospholipid syndrome']
